» Articles » PMID: 30568654

Multivariate Computational Analysis of Gamma Delta T Cell Inhibitory Receptor Signatures Reveals the Divergence of Healthy and ART-Suppressed HIV+ Aging

Overview
Journal Front Immunol
Date 2018 Dec 21
PMID 30568654
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Even with effective viral control, HIV-infected individuals are at a higher risk for morbidities associated with older age than the general population, and these serious non-AIDS events (SNAEs) track with plasma inflammatory and coagulation markers. The cell subsets driving inflammation in aviremic HIV infection are not yet elucidated. Also, whether ART-suppressed HIV infection causes premature induction of the inflammatory events found in uninfected elderly or if a novel inflammatory network ensues when HIV and older age co-exist is unclear. In this study we measured combinational expression of five inhibitory receptors (IRs) on seven immune cell subsets and 16 plasma markers from peripheral blood mononuclear cells (PBMC) and plasma samples, respectively, from a HIV and Aging cohort comprised of ART-suppressed HIV-infected and uninfected controls stratified by age (≤35 or ≥50 years old). For data analysis, multiple multivariate computational algorithms [cluster identification, characterization, and regression (CITRUS), partial least squares regression (PLSR), and partial least squares-discriminant analysis (PLS-DA)] were used to determine if immune parameter disparities can distinguish the subject groups and to investigate if there is a cross-impact of aviremic HIV and age on immune signatures. IR expression on gamma delta (γδ) T cells exclusively separated HIV+ subjects from controls in CITRUS analyses and secretion of inflammatory cytokines and cytotoxic mediators from γδ T cells tracked with TIGIT expression among HIV+ subjects. Also, plasma markers predicted the percentages of TIGIT+ γδ T cells in subjects with and without HIV in PSLR models, and a PLS-DA model of γδ T cell IR signatures and plasma markers significantly stratified all four of the subject groups (uninfected younger, uninfected older, HIV+ younger, and HIV+ older). These data implicate γδ T cells as an inflammatory driver in ART-suppressed HIV infection and provide evidence of distinct "inflamm-aging" processes with and without ART-suppressed HIV infection.

Citing Articles

In-depth Analysis of the HIV Reservoir Confirms Effectiveness and Safety of Dolutegravir/Lamivudine in a Phase 4 Randomized Controlled Switch Trial (RUMBA).

De Scheerder M, Degroote S, Delporte M, Kiselinova M, Trypsteen W, Vincke L J Infect Dis. 2024; 231(1):e91-e100.

PMID: 39226296 PMC: 11793038. DOI: 10.1093/infdis/jiae405.


Dual role of circulating and mucosal Vδ1 T cells in the control of and contribution to persistent HIV-1 infection.

Mann B, Sanz M, Clohosey M, Langlands K, Chitrakar A, Moreno C Res Sq. 2024; .

PMID: 39149467 PMC: 11326412. DOI: 10.21203/rs.3.rs-4784403/v1.


Cardiac and Renal Comorbidities in Aging People Living With HIV.

McCutcheon K, Nqebelele U, Murray L, Thomas T, Mpanya D, Tsabedze N Circ Res. 2024; 134(11):1636-1660.

PMID: 38781295 PMC: 11122746. DOI: 10.1161/CIRCRESAHA.124.323948.


Therapeutic and immunomodulatory potentials of mesenchymal stromal/stem cells and immune checkpoints related molecules.

Hazrati A, Malekpour K, Khorramdelazad H, Rajaei S, Hashemi S Biomark Res. 2024; 12(1):35.

PMID: 38515166 PMC: 10958918. DOI: 10.1186/s40364-024-00580-2.


Targeting the NF-κB pathway as a potential regulator of immune checkpoints in cancer immunotherapy.

Ebrahimi N, Abdulwahid A, Mansouri A, Karimi N, Bostani R, Beiranvand S Cell Mol Life Sci. 2024; 81(1):106.

PMID: 38418707 PMC: 10902086. DOI: 10.1007/s00018-023-05098-8.


References
1.
Serrano-Villar S, Sainz T, Lee S, Hunt P, Sinclair E, Shacklett B . HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. PLoS Pathog. 2014; 10(5):e1004078. PMC: 4022662. DOI: 10.1371/journal.ppat.1004078. View

2.
Jones R, Ndhlovu L, Barbour J, Sheth P, Jha A, Long B . Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med. 2008; 205(12):2763-79. PMC: 2585847. DOI: 10.1084/jem.20081398. View

3.
Brenchley J, Price D, Schacker T, Asher T, Silvestri G, Rao S . Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006; 12(12):1365-71. DOI: 10.1038/nm1511. View

4.
Martin B, Hirota K, Cua D, Stockinger B, Veldhoen M . Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity. 2009; 31(2):321-30. DOI: 10.1016/j.immuni.2009.06.020. View

5.
Hatano H . Immune activation and HIV persistence: considerations for novel therapeutic interventions. Curr Opin HIV AIDS. 2013; 8(3):211-6. PMC: 4041488. DOI: 10.1097/COH.0b013e32835f9788. View